Ikarian Capital’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 141 |
|
|
2025
Q1 | – | Sell |
-70,000
| Closed | -$2.7M | – | 160 |
|
|
2024
Q4 | $2.7M | Buy |
+70,000
| New | +$2.7M | 0.37% | 38 |
|
|
2024
Q1 | – | Sell |
-319,000
| Closed | -$7.31M | – | 114 |
|
|
2023
Q4 | $7.31M | Buy |
+319,000
| New | +$7.31M | 0.68% | 18 |
|
|
2023
Q3 | – | Sell |
-35,000
| Closed | -$967K | – | 110 |
|
|
2023
Q2 | $967K | Buy |
+35,000
| New | +$967K | 0.15% | 46 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 100 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 149 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 172 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 175 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 181 |
|
|
2020
Q2 | – | Sell |
-158,222
| Closed | -$1.12M | – | 123 |
|
|
2020
Q1 | $1.12M | Buy |
158,222
+79,896
| +102% | +$564K | 0.08% | 49 |
|
|
2019
Q4 | $552K | Buy |
+78,326
| New | +$552K | 0.09% | 38 |
|